Search

Displaying results 6371 - 6380 of 10000 in total
  1. Drug

    Bassia scoparia pollen

    go.drugbank.com/drugs/DB10928
    Approved

    Bassia scoparia pollen is mainly used in allergenic testing.

    Products: Center-AL - Kochia Scoparia Pollen
  2. Drug

    Cyclachaena xanthifolia pollen

    go.drugbank.com/drugs/DB10929
    Approved

    Cyclachaena xanthifolia pollen is mainly used in allergenic testing.

  3. Drug

    Ambrosia ambrosioides pollen

    go.drugbank.com/drugs/DB10947
    Approved

    Ambrosia ambrosioides pollen is mainly used in allergenic testing.

  4. Drug

    Phoenix dactylifera pollen

    go.drugbank.com/drugs/DB10950
    Approved

    Phoenix dactylifera pollen is mainly used in allergenic testing.

  5. Drug

    Phalaris minor pollen

    go.drugbank.com/drugs/DB10963
    Approved

    Phalaris minor pollen is mainly used in allergenic testing.

  6. Drug

    Ulmus parvifolia pollen

    go.drugbank.com/drugs/DB11005
    Approved

    Ulmus parvifolia pollen is mainly used in allergenic testing.

  7. Drug

    Schinus terebinthifolia pollen

    go.drugbank.com/drugs/DB21762
    Approved

    Schinus terebinthifolia pollen is mainly used in allergenic testing.

  8. Drug

    Butyric Acid

    go.drugbank.com/drugs/DB03568
    Investigational

    A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.

    Synonyms: N-butyric acid, N-butanoic acid
  9. Drug

    Ofirnoflast

    go.drugbank.com/drugs/DB21679
    Investigational

    Ofirnoflast is under investigation in clinical trial NCT07052006 (HT-6184 in Subjects With MDS). Ofirnoflast has a monoisotopic molecular weight of 501.15 Da. … Ofirnoflast is a small molecule drug. The usage of the INN stem '-noflast' in the name indicates that Ofirnoflast is a inflammasome protein NLRP3 inhibitor.

  10. Drug

    Elsibucol

    go.drugbank.com/drugs/DB05840
    Experimental

    in chronic organ transplant rejection. … AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of grafted blood vessels, known as transplant arteritis, common